170 related articles for article (PubMed ID: 8884778)
1. Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain.
Funa K; Yamada N; Brodin G; Pietz K; Ahgren A; Wictorin K; Lindvall O; Odin P
Neuroscience; 1996 Oct; 74(3):825-33. PubMed ID: 8884778
[TBL] [Abstract][Full Text] [Related]
2. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
[TBL] [Abstract][Full Text] [Related]
3. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
4. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
Chadi G; Cao Y; Pettersson RF; Fuxe K
Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
[TBL] [Abstract][Full Text] [Related]
7. Identification and comparative analysis of differentially expressed proteins in rat striatum following 6-hydroxydopamine lesions of the nigrostriatal pathway: up-regulation of amyloid precursor-like protein 2 expression.
Shen Y; Yu Y; Guo H; Tang Z; Yu FS; Zhou J
Eur J Neurosci; 2002 Sep; 16(5):896-906. PubMed ID: 12372026
[TBL] [Abstract][Full Text] [Related]
8. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
9. Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study.
Ryu JH; Yanai K; Watanabe T
Neurosci Lett; 1994 Aug; 178(1):19-22. PubMed ID: 7816330
[TBL] [Abstract][Full Text] [Related]
10. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
11. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
Smith JA; Leslie FM; Broide RS; Loughlin SE
Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
Mohapel P; Frielingsdorf H; Häggblad J; Zachrisson O; Brundin P
Neuroscience; 2005; 132(3):767-76. PubMed ID: 15837137
[TBL] [Abstract][Full Text] [Related]
14. Recovery after nigral grafting in 6-hydroxydopamine lesioned rats is due to graft function and not significantly influenced by the remaining ipsilateral or contralateral host dopaminergic system.
Lopez-Martin E; Rozas G; Guerra MJ; Labandeira-Garcia JL
Brain Res; 1999 Sep; 842(1):119-31. PubMed ID: 10526102
[TBL] [Abstract][Full Text] [Related]
15. Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats.
Anichtchik OV; Huotari M; Peitsaro N; Haycock JW; Männistö PT; Panula P
Eur J Neurosci; 2000 Nov; 12(11):3823-32. PubMed ID: 11069577
[TBL] [Abstract][Full Text] [Related]
16. Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway.
Aliaga E; Cárcamo C; Abarca J; Tapia-Arancibia L; Bustos G
Brain Res Mol Brain Res; 2000 Jun; 79(1-2):150-5. PubMed ID: 10925152
[TBL] [Abstract][Full Text] [Related]
17. 6-OHDA denervation substantially decreases DCC mRNA levels in rat substantia nigra compacta.
Volenec A; Zetterström TS; Flanigan TP
Neuroreport; 1998 Nov; 9(16):3553-6. PubMed ID: 9858358
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
19. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat.
Blum M; Wu G; Mudó G; Belluardo N; Andersson K; Agnati LF; Fuxe K
Neuroscience; 1996 Jan; 70(1):169-77. PubMed ID: 8848122
[TBL] [Abstract][Full Text] [Related]
20. 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra.
Venero JL; Beck KD; Hefti F
Neuroreport; 1994 Jan; 5(4):429-32. PubMed ID: 8003668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
